"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."
Sir John Bell
Chief Executive, James McLaughlin offers his thoughts after the announcement from Chancellor,
Rishi Sunak regarding a £750m package to aid charities in the wake of the COVID-19 pandemic.
Subscribe to our newsletter
Subscribe to our newsletter
How funds raised for Cure Leukaemia help save lives